Hospital-at-Home Monitoring & Care Technologies Market (2026 - 2033)

Hospital-at-Home Monitoring & Care Technologies Market Summary

The global hospital-at-home monitoring & care technologies market size was valued at USD 25.2 billion in 2025 and is projected to grow from USD 27.8 billion in 2026 to USD 59.3 billion by 2033, at a CAGR of 11.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.4% in 2025. This growth is attributed to the growing need to reduce hospital bed pressure, rising adoption of remote monitoring and connected care technologies, and increasing demand for cost-efficient acute care delivery at home.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

To learn more about this report, Download Free Sample Report

Market Dynamic

The hospital-at-home monitoring & care technologies market is driven by hospital capacity constraints, increasing adoption of hospital-at-home and virtual ward models, rising chronic disease burden, and growing demand for continuous patient monitoring and early deterioration detection. Advancements in AI-enabled analytics, wearable sensors, wireless connectivity, and digital care platforms are further supporting adoption. However, high technology costs, data privacy and cybersecurity concerns, interoperability challenges, connectivity limitations, and regulatory requirements may restrain market growth.

Market Concentration & Characteristics

The degree of innovation in the hospital-at-home monitoring & care technologies market is high, driven by advances in multimodal wearable monitors that continuously capture multiple physiological parameters and transmit data to clinicians, enabling remote monitoring and early detection of patient deterioration. For instance, in July 2026, LifeLens Technologies received FDA 510(k) clearance for expanded indications of its Wearable Physiological Monitoring system, adding SpO₂, heart rate, respiratory rate, heart rate variability, and skin temperature to ECG monitoring. This highlights the shift toward multimodal patches for continuous monitoring in home-based care.

"Managing complex disease requires monitoring solutions that deliver the breadth of clinical, environmental, and contextual data needed to make informed treatment decisions" But breadth alone isn't enough, the data has to be trusted. This clearance, along with multiple actively enrolling clinical studies, reflects our commitment to closing that confidence gap with clinical validation and FDA regulatory review. We're building the evidence base that turns continuous physiological data into meaningful clinical insight."

Landy Toth, founder and CEO of LifeLens.

The level of merger and acquisitions activities in the market is high, as companies seek to strengthen patient-monitoring portfolios, expand technological capabilities, and access advanced sensing and AI-enabled technologies. M&A activity is also expanding capabilities across acute and home-based care. For instance, in June 2026, Danaher completed its acquisition of Masimo Corporation, a patient-monitoring company specializing in pulse oximetry, sensors, and other monitoring technologies. The acquisition added AI-enabled patient monitoring capabilities to Danaher's diagnostics portfolio and is expected to strengthen its presence in acute-care monitoring.

To learn more about this report, Download Free Sample Report

The impact of regulations is significant in this market, as connected medical devices and digital platforms must meet requirements for safety, performance, clinical validation, cybersecurity, and data privacy. In the U.S., applicable medical devices require FDA clearance or approval, while in Europe, manufacturers must comply with the EU Medical Device Regulation (MDR) and applicable data protection requirements. In China, medical devices are regulated by the National Medical Products Administration (NMPA), with Class II and Class III devices generally requiring registration and compliance with safety, effectiveness, quality, and clinical evaluation requirements before commercialization.

The regional expansion of the hospital-at-home monitoring & care technologies market is significant, supported by growing healthcare digitization, increasing demand for home-based care, and improving healthcare infrastructure across emerging markets. Key players are expanding through regional partnerships, distribution networks, regulatory approvals, and localized product launches to increase access to connected monitoring and digital care technologies.

Analyst Perspective

The hospital-at-home monitoring & care technologies market is driven by the rising adoption of physiological monitoring wearable sensors, wireless connectivity, and AI-enabled analytics. Adoption is shifting toward multimodal, continuous, and clinically validated technologies that enable remote monitoring and earlier detection of patient deterioration. Market players such as Medtronic, GE HealthCare, Philips, ResMed, Mindray, Huma, Doccla, Biofourmis, VitalConnect, and VivaLNK are strengthening their portfolios through wearable monitoring, AI-enabled analytics, digital care platforms, product innovation, partnerships, and expansion into home-based care. Competition remains high as medical-device and digital players leverage clinical expertise, distribution networks, continuous monitoring, AI, and integrated hospital-to-home solutions.

Technology Insights

The monitoring segment dominated the market with a revenue share of 40.8% in 2025. The segment dominance is due to increasing use of wearable and connected devices to continuously measure ECG, heart rate, SpO₂, blood pressure, temperature, and respiratory rate in patients receiving care at home, providing clinicians with real-time physiological data for early intervention. Advances in multimodal sensors, wireless connectivity, miniaturized devices, and continuous monitoring technologies also drive market growth. For instance, in March 2026, Current Health partnered with Cardinal Health’s Velocare to support hospital-at-home programs through the delivery, installation, and retrieval of Current Health’s in-home clinical monitoring kits. The collaboration supports continuous monitoring, clinical outreach, and timely escalation, highlighting the growing use of connected monitoring in hospital-at-home care.

The digital care technologies segment is expected to grow at the fastest CAGR from 2026 to 2033. Growth is driven by increasing adoption of RPM platforms, virtual wards, telehealth, clinical alerting, AI-based analytics, and patient engagement solutions. These technologies integrate patient data, enable remote communication with care teams, and support digital clinical workflows. Growth is further supported by the need to scale hospital-at-home programs, with AI-enabled analytics, automated alerts, and digital care pathways helping clinicians identify deterioration earlier and coordinate patient care more efficiently.

End Use Insights

The hospitals segment held the largest revenue share of 58.0% in 2025. This dominance is driven by hospitals expanding hospital-at-home programs to extend acute and post-acute care beyond traditional inpatient settings while maintaining clinical oversight through remote monitoring and digital care technologies. The increasing use of connected monitoring devices, virtual wards, and integrated clinical platforms is strengthening hospitals' ability to monitor patients remotely and manage care transitions.

To learn more about this report, Download Free Sample Report

The home healthcare provider segment is expected to grow at the fastest CAGR of 12.9% during the forecast period. This growth is driven by the expansion of home-based acute care, remote patient monitoring, and technology-enabled clinical services. These providers increasingly combine skilled nursing and home-care services with connected monitoring, telehealth, and digital care platforms, creating greater demand for hospital-at-home technologies.

Regional Insights

North America hospital-at-home monitoring & care technologies market dominated the global market with a revenue share of 40.4% in 2025. This dominance is due to the advanced healthcare infrastructure, established remote patient monitoring, high healthcare expenditure, and strong adoption of connected monitoring technologies. Key players include Medtronic, GE HealthCare, Philips, ResMed, Mindray, Huma, Doccla, Biofourmis, VitalConnect, and VivaLNK strengthening the market in the region. For instance, in August 2026, iRhythm announced an agreement to acquire VitalConnect for approximately USD 287.5 million, thereby expanding its cardiac monitoring portfolio across ambulatory, inpatient, and hospital-to-home care settings.

To learn more about this report, Download Free Sample Report

U.S. Hospital-at-Home Monitoring & Care Technologies Market Trends

The U.S. dominated the North America market in 2025, supported by high healthcare expenditure, chronic disease prevalence, established remote patient monitoring practices, and advanced healthcare infrastructure. The presence of major players, including Medtronic, GE HealthCare, Philips, ResMed, Mindray, Huma, Doccla, Biofourmis, VitalConnect, and VivaLNK, further supports market development. For instance, in July 2026, Dexcom was selected as the first participant in the FDA's TEMPO Digital Health Devices Pilot Program, supporting the integration of Dexcom G7 and Stelo data with contextual health information and AI-powered insights for chronic disease management. This development highlights the growing integration of AI and connected monitoring technologies into U.S. digital healthcare.

Europe Hospital-at-Home Monitoring & Care Technologies Market Trends

Hospital-at-home monitoring & care technologies market in Europe held a significant share of the global market in 2025, supported by aging populations, chronic disease prevalence, established healthcare infrastructure, and growing adoption of remote monitoring and virtual care. For instance, in August 2026, Philips announced collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare to expand its open patient-monitoring ecosystem, integrating wearable and out-of-hospital technologies for continuous patient monitoring from hospital to home. This development supports continuous patient monitoring during hospital-to-home transitions and recovery at home.

Hospital-at-home monitoring & care technologies market in UK supported by established healthcare infrastructure, an aging population, chronic disease burden, and the NHS's focus on virtual wards and home-based care. Increasing adoption of remote patient monitoring and connected technologies is supporting demand for continuous ECG, glucose, respiratory, and multimodal monitoring. The expansion of virtual wards and digital care pathways is expected to further support market growth.

Germany hospital-at-home monitoring & care technologies market is driven by the advanced healthcare infrastructure, an aging population, high healthcare expenditure, and a strong medical-device industry drive the market growth. Increasing demand for continuous monitoring and home-based care is supporting adoption of clinical-grade wearable technologies. Growing integration of connected monitoring devices with healthcare workflows is expected to further support market expansion.

Asia Pacific Hospital-at-Home Monitoring & Care Technologies Market Trends

Asia Pacific is expected to grow at the fastest CAGR of 12.9% from 2026 to 2033. Market growth is due to by expanding healthcare infrastructure, increasing chronic disease prevalence, and rising adoption of remote and connected patient monitoring. For instance, Vivalink provides clinically validated wearable monitoring technologies that continuously measure parameters such as ECG, heart rate, respiratory rate, SpO₂, and temperature, supporting remote patient monitoring across healthcare settings.

Hospital-at-home monitoring & care technologies market in Japan is driven by strong healthcare infrastructure, an aging population, high healthcare expenditure, and a well-established medical-device industry. The increasing need for continuous monitoring of older adults and patients with chronic conditions is supporting demand for connected and clinical-grade wearable technologies. Growing adoption of digital healthcare and remote monitoring is expected to further support market growth.

Hospital-at-home monitoring & care technologies market in China represents a significant growth opportunity, driven by its large patient population, expanding healthcare infrastructure, increasing chronic disease burden, and growing healthcare digitization. Investments in digital health and remote patient monitoring are increasing demand for continuous physiological monitoring technologies, while domestic and international medical-device manufacturers are expanding the availability of connected monitoring solutions.

Latin America Hospital-at-Home Monitoring & Care Technologies Market Trends

Hospital-at-home monitoring & care technologies market in Latin America is expected to grow significantly, driven by healthcare digitization, rising chronic disease prevalence, increasing adoption of remote patient monitoring, and improving healthcare infrastructure. Growing use of home-based care and connected healthcare technologies is supporting demand for wearable ECG, glucose, respiratory, and multimodal monitoring solutions.

Middle East & Africa Hospital-at-Home Monitoring & Care Technologies Market Trends

Hospital-at-home monitoring & care technologies market in Middle East & Africa is driven by healthcare modernization, increasing healthcare investments, digital health adoption, and growing demand for remote patient monitoring. Expanding healthcare infrastructure and home-based care are creating opportunities for connected physiological monitoring, wearable ECG, pulse oximetry, glucose, and multimodal monitoring technologies.

Key Hospital-at-Home Monitoring & Care Technologies Company Insights

Key players in the hospital-at-home monitoring & care technologies market are strengthening their positions through strategic partnerships, and geographic expansion. Major companies such as Medtronic, Koninklijke Philips N.V., GE HealthCare Technologies Inc., ResMed Inc., and Biofourmis, Inc. are expanding capabilities across hospital-to-home monitoring and remote care.

Key Hospital-at-Home Monitoring & Care Technologies Companies

The following key companies have been profiled for this study on the hospital-at-home monitoring & care technologies market.

Recent Developments

• In August 2026, Empatica received FDA 510(k) clearance for its Health Monitoring Platform for Parkinson's, which combines clinical-grade wearables, digital biomarkers, and connected monitoring to continuously assess symptoms including bradykinesia, dyskinesia, tremor, sleep, and medication compliance. This development highlights the expansion of wearable and digital monitoring technologies into remote neurological disease management.

"Wearable monitoring enhances our understanding of how Parkinson's symptoms change daily and respond to treatment, Bringing objective, real-world data into clinical care can assist clinicians in making more informed, personalized decisions and better support people living with Parkinson's."

Ritesh Ramdhani, MD, Associate Professor of Neurology and Director of the Deep Brain Stimulation Program

• In May 2026, Johnson & Johnson highlighted the use of remote patient monitoring and AI-powered approaches to collect patient data through wearables and apps, providing healthcare providers with real-time insights to support more timely treatment decisions.

• In March 2026, Philips partnered with Cuviva to integrate remote patient monitoring and patient-engagement technologies into its monitoring ecosystem, enabling physiological data from connected devices to be securely transmitted to clinicians through cloud-based dashboards and supporting Hospital-at-Home care.

• In October 2024, BioIntelliSense received FDA clearance for its BioButton Multi-Patient wearable and BioDashboard system for continuous patient monitoring. The medical-grade wearable enables automated collection of vital signs for continuous monitoring across hospital units and hospital-level care at home.

Global Hospital-at-Home Monitoring & Care Technologies Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hospital-at-home monitoring & care technologiesmarket report based on technology, end use, and regions.

To learn more about this report, Download Free Sample Report

• Technology Outlook (Revenue, USD Billion, 2021 - 2033)

  • Monitoring Technologies

    • Multiparameter Patient Monitors

    • Pulse Oximeters

    • ECG Monitors

    • Blood Pressure Monitors

    • Temperature Monitors

    • Respiratory Rate Monitors

    • Wearable Patient Monitors

    • Continuous Monitoring Patches

  • Respiratory Care Technologies

    • Positive Airway Pressure (PAP) Devices

    • Non-Invasive Ventilation Devices

    • Invasive Ventilation Devices

    • Oxygen Concentrators

    • Nebulizers

  • Digital Care Technologies

    • RPM Platforms

    • Virtual Nursing Platforms

    • Telehealth & Platforms

    • Clinical Alert & Escalation Systems

    • AI-Based Deterioration Prediction

    • Patient Engagement Platforms

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospitals

  • Home Healthcare Providers

  • Specialty Clinics

  • Other

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The hospital-at-home monitoring & care technologies market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each hospital-at-home monitoring & care technologies segment quantified using the revenue-capture definitions in the table below.

Market Definition- Hospital-at-Home Monitoring & Care Technologies market includes devices, software, connectivity, and digital tools that enable healthcare professionals to remotely monitor and support patients receiving hospital-level or acute care at home. The market covers technologies for physiological monitoring, respiratory support, clinical alerting, and digital care coordination. Market revenue is captured from the sale, licensing, subscription, and deployment of these technologies.

Delivered Customizations

This report has been delivered with the following In-depth customizations